CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 72 filers reported holding CARDIFF ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,320,000 | -79.6% | 1,742,123 | -50.6% | 0.00% | -77.8% |
| Q4 2021 | $21,170,000 | -10.1% | 3,523,012 | -0.3% | 0.01% | -10.0% |
| Q3 2021 | $23,541,000 | +12.3% | 3,533,381 | +12.1% | 0.01% | +11.1% |
| Q2 2021 | $20,954,000 | -22.9% | 3,151,167 | +7.3% | 0.01% | -25.0% |
| Q1 2021 | $27,187,000 | -29.3% | 2,937,182 | +37.4% | 0.01% | -33.3% |
| Q4 2020 | $38,434,000 | +167.5% | 2,137,671 | +111.1% | 0.02% | +157.1% |
| Q3 2020 | $14,368,000 | – | 1,012,818 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |